학술논문

Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Document Type
Article
Source
In: American Journal of Hematology. (American Journal of Hematology, May 2024, 99(5):836-843)
Subject
Language
English
ISSN
10968652
03618609